PARIS (dpa-AFX) - Sanofi's (SNYNF, SNY) latest formulation of Fluzone Intradermal vaccine for protecting against four strains of influenza has been approved by the Food and Drug Administration.
The vaccine contained three strains of the virus previously. The present form of the vaccine was developed to help address B-strain mismatches and broaden coverage against influenza, the company said in a press release Friday.
Copyright RTT News/dpa-AFX